Sitting next to President Obama, Israel PM Benjamin Netanyahu says no to 1967 borders

WASHINGTON -- Israeli Prime Minister Benjamin Netanyahu sat alongside President Barack Obama on Friday and declared that Israel would not withdraw to 1967 borders to help make way for an adjacent Palestinian state. Obama had called on Israel to be willing to do just that a day earlier.

The Israeli leader said he would make some concessions but Israel would not go back to the lines from decades earlier because they would be "indefensible."

For his part, Obama said that there were differences of formulations and language but that such disputes are going to happen "between friends."

The president never mentioned the 1967 borders as the two men talked with reporters. The leaders spoke after a lengthy meeting in the Oval Office, amid tense times.

Obama said in his speech on Thursday that the United States supports creation of a Palestinian state based on the border lines that existed before the 1967 Six Day War in which Israel forces occupied east Jerusalem, the West Bank and Gaza. The comment drew angry criticism in Israel, and Netanyahu made clear after meeting with Obama that the idea was unacceptable.

"We cannot go back to those indefensible lines," said Netanyahu.

Both Obama and Netanyahu said they shared a desire to get to peace and played down disagreements. "We may have differences here and there," Netanyahu said.

But there was no sign of resolution of the many barriers that stand between Israel and the Palestinians, more now than last September when Obama brought the two parties together to call for a peace deal within a year -- a deadline that now looks unattainable.

Netanyahu said his nation could not negotiate with a newly constituted Palestinian unity government that includes the radical Hamas movement, which refuses to recognize Israel's right to exist. He said that Palestinian President Mahmoud Abbas had to choose between continuing the deal with Hamas and making peace with Israel.

FDA approves new HIV drug from Johnson & Johnson

WASHINGTON -- The Food and Drug Administration says it approved a new HIV drug from Johnson & Johnson for patients who have not been treated with other medications for the virus.

The once-a-day pill Edurant works by blocking the virus from reproducing. It is designed to be used with other drugs that reduce levels of HIV in the blood.

FDA officials say the approval provides an additional option to HIV patients, who respond differently to various medications.

The FDA approved the drug based on a study showing it was as effective as Sustiva, an older HIV drug already on the market.